Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2026-01-24 @ 11:36 PM
Study NCT ID:
NCT04680468
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2020-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
Sponsor:
University of Pennsylvania
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myeloma | View |
Keywords: